Long-Term Measures of Dyslipidemia, Inflammation, and Oxidative Stress in Rats Fed a High-Fat/High-Fructose Diet.


Journal

Lipids
ISSN: 1558-9307
Titre abrégé: Lipids
Pays: United States
ID NLM: 0060450

Informations de publication

Date de publication:
01 2019
Historique:
received: 15 08 2018
revised: 04 01 2019
accepted: 04 01 2019
pubmed: 16 2 2019
medline: 3 9 2019
entrez: 16 2 2019
Statut: ppublish

Résumé

Inflammation and oxidative stress are thought to be involved in, or associated with, the development of obesity, dyslipidemia, hepatic steatosis, and insulin resistance. This work was designed to determine the evolution of inflammation and oxidative stress during onset and progression of hepatic steatosis and glucose intolerance. Seventy-five male Wistar rats were divided to control and high-fat high-fructose (HFHFr) groups. A subgroup of each group was sacrificed at 4, 8, 12, 16, and 20 weeks. HFHFr-fed rats exhibited overweight, glucose intolerance, and hepatic steatosis with increased contents of hepatic diacylglycerols and ceramides. The HFHFr diet increased hepatic interleukin 6 (IL-6) protein and adipose tissue CCL5 gene expression and hepatic nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity but not mitochondrial reactive oxygen species (ROS) production. The HFHFr diet decreased plasma and liver levels of isoprostanoid metabolites as well as plasma thiobarbituric acid-reactive substance (TBARS) levels. Hepatic glutathione content was decreased with a moderate decrease in superoxide dismutase (SOD) and glutathione peroxidase (GPx) with the HFHFr diet. Overall, HFHFr diet led to hepatic lipid accumulation and glucose intolerance, which were accompanied by only moderate inflammation and oxidative stress. Most of these changes occurred at the same time and as early as 8 or 12 weeks of diet treatment. This implies that oxidative stress may be the result, not the cause, of these metabolic alterations, and suggests that marked hepatic oxidative stress should probably occur at the end of the steatotic stage to result in frank insulin resistance and steatohepatitis. These findings need to be further evaluated in other animal species as well as in human studies.

Identifiants

pubmed: 30767221
doi: 10.1002/lipd.12128
doi:

Substances chimiques

Blood Glucose 0
Reactive Oxygen Species 0
Thiobarbituric Acid Reactive Substances 0
Fructose 30237-26-4
Superoxide Dismutase EC 1.15.1.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

81-97

Informations de copyright

© 2019 AOCS.

Auteurs

Christine Feillet-Coudray (C)

DMEM (Dynamique Musculaire & Métabolisme) INRA, University of Montpellier, 2 Place Viala, 34060, Montpellier, France.

Gilles Fouret (G)

DMEM (Dynamique Musculaire & Métabolisme) INRA, University of Montpellier, 2 Place Viala, 34060, Montpellier, France.

Claire Vigor (C)

Institut des Biomolécules Max Mousseron, IBMM, University of Montpellier, CNRS, ENSCM, 15 Avenue Charles Flahault, 34090, Montpellier, France.

Béatrice Bonafos (B)

DMEM (Dynamique Musculaire & Métabolisme) INRA, University of Montpellier, 2 Place Viala, 34060, Montpellier, France.

Bernard Jover (B)

PhyMedExp, University of Montpellier, INSERM, CNRS, 371 avenue Doyen Gaston Giraud, 34295, Montpellier, France.

Agnieszka Blachnio-Zabielska (A)

Physiology Department, Medical University of Bialystok, Jana Kilińskiego 1, 15-089, Bialystok, Poland.
Epidemiology and Metabolic Disorders Department, Medical University of Bialystok, Jana Kilińskiego 1, 15-089, Bialystok, Poland.

Jennifer Rieusset (J)

UMR U1060, INSERM, Faculté de médecine Lyon-Sud, 165 Chemin du Grand Revoyet, 69921 Oullins, France.

François Casas (F)

DMEM (Dynamique Musculaire & Métabolisme) INRA, University of Montpellier, 2 Place Viala, 34060, Montpellier, France.

Sylvie Gaillet (S)

DMEM (Dynamique Musculaire & Métabolisme) INRA, University of Montpellier, 2 Place Viala, 34060, Montpellier, France.

Jean Francois Landrier (JF)

Aix Marseille University, INSERM, INRA, C2VN, 27 boulevard Jean Moulin 13385, Marseille, France.

Thierry Durand (T)

Institut des Biomolécules Max Mousseron, IBMM, University of Montpellier, CNRS, ENSCM, 15 Avenue Charles Flahault, 34090, Montpellier, France.

Charles Coudray (C)

DMEM (Dynamique Musculaire & Métabolisme) INRA, University of Montpellier, 2 Place Viala, 34060, Montpellier, France.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH